...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Evaluation of bisbenzamidines as inhibitors for matriptase-2
【24h】

Evaluation of bisbenzamidines as inhibitors for matriptase-2

机译:评估双苯甲m作为Matriptase-2抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

The serine protease matriptase-2 has attracted much attention as a potential target for the treatment of iron overload diseases. In this study, a series of 27 symmetric, achiral bisbenzamidines was evaluated for inhibitory activity against human matriptase-2, against the closely related enzyme human matriptase, as well as against human thrombin, bovine factor Xa and human trypsin. The conformationally restricted piperazine derivative 19 and the oxamide-derived bisbenzamidine 1 were identified as the most potent inhibitors of this series for matriptase-2 and matriptase, respectively. (C) 2016 Elsevier Ltd. All rights reserved.
机译:丝氨酸蛋白酶Matriptase-2作为治疗铁超负荷疾病的潜在靶点已引起了广泛关注。在这项研究中,评估了一系列27种对称的非手性双苯甲m对人matriptase-2,紧密相关的人matriptase酶以及人凝血酶,牛因子Xa和人胰蛋白酶的抑制活性。构象受限的哌嗪衍生物19和草酰胺衍生的双苯甲m1分别被确定为该系列中对matriptase-2和matriptase最有效的抑制剂。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号